Burden of influenza B virus infections in Scotland in 2012/13 and epidemiological investigations between 2000 and 2012

Eurosurveillance

Volumn 19, Issue 37, 2014, Pages

  Harvala, H ^a   Smith, D ^b   Salvatierra, K ^b   Gunson, R ^c   von Wissmann, B ^d   Reynolds, A ^d   Frew, C ^c   MaClean, A ^c   Hunt, A ^e   Yirrell, D ^f   Simmonds, P ^b   McMenamin, J ^d   Templeton, K ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c Health Protection Scotland ^*  (United Kingdom)

^d HEALTH PROTECTION SCOTLAND   (United Kingdom)

^e ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^f NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; ZANAMIVIR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; DISEASE SEVERITY; GENE SEQUENCE; HUMAN; INCIDENCE; INFLUENZA; INFLUENZA A; INFLUENZA B; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MORTALITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNITED KINGDOM; VIRUS LOAD;

EID: 84907736121     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.37.20903     Document Type: Article

References (24)

1. Glezen WP, Schmier JK, Kuehn CM, Ryan KJ, Oxford J. The burden of influenza B: a structured literature review. Am J Public Health. 2013;103(3):e43-51. http://dx.doi.org/10.2105/ AJPH.2012.301137
2. McCullers JA, Saito T, Iverson AR. Multiple genotypes of influenza B virus circulated between 1979 and 2003. J Virol. 2004;78(23):12817-28. http://dx.doi.org/10.1128/ JVI.78.23.12817-12828.2004
3. Rota PA, Wallis TR, Harmon MW, Rota JS, Kendal AP, Nerome K. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology. 1990;175(1):59-68. http:// dx.doi.org/10.1016/0042-6822(90)90186-U
4. Belshe RB, Coelingh K, Ambrose CS, Woo JC, Wu X. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine. 2010;28(9):2149-56. http://dx.doi.org/10.1016/j. vaccine.2009.11.068
5. Gunson RN, Collins TC, Carman WF. Real-time RT-PCR detection of 12 respiratory viral infections in four triplex reactions. J Clin Virol. 2005;33(4):341-4. http://dx.doi.org/10.1016/j. jcv.2004.11.025
6. Templeton KE, Scheltinga SA, Beersma MF, Kroes AC, Claas EC. Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4. J Clin Microbiol. 2004;42(4):1564-9. http://dx.doi. org/10.1128/JCM.42.4.1564-1569.2004
7. Hardelid P, Fleming DM, McMenamin J, Andrews N, Robertson C, SebastianPillai P, et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill. 2011;16(2):pii=19763.
8. Scotland’s Census 2011. Edinburgh: General Register Office for Scotland. [Accessed 7 Mar 2014.] Available from: http://www. scotlandscensus.gov.uk/ods-web/standard-outputs.html
9. Simmonds P. SSE: a nucleotide and amino acid sequence analysis platform. BMC Res Notes. 2012;5:50. http://dx.doi. org/10.1186/1756-0500-5-50
10. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28(10):2731-9. http:// dx.doi.org/10.1093/molbev/msr121
11. Biere B, Bauer B, Schweiger B. Differentiation of influenza B virus lineages Yamagata and Victoria by real-time PCR. J Clin Microbiol. 2010;48(4):1425-7. http://dx.doi.org/10.1128/ JCM.02116-09
12. Chan PK, Chan MC, Cheung JL, Lee N, Leung TF, Yeung AC, et al. Influenza B lineage circulation and hospitalization rates in a subtropical city, Hong Kong, 2000-2010. Clin Infect Dis. 2013;56(5):677-84. http://dx.doi.org/10.1093/cid/cis885
13. Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother. 2012;8(1):81-8 http:// dx.doi.org/10.4161/hv.8.1.17623
14. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med. 2001;344(12):889-96. http://dx.doi.org/10.1056/ NEJM200103223441204
15. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342(4):225-31. http://dx.doi.org/10.1056/ NEJM200001273420401
16. Olson DR, Heffernan RT, Paladini M, Konty K, Weiss D, Mostashari F. Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLoS Med. 2007;4(8):e247. http://dx.doi.org/10.1371/journal.pmed.0040247
17. Lunelli A, Rizzo C, Puzelli S, Bella A, Montomoli E, Rota MC, et al. Understanding the dynamics of seasonal influenza in Italy: incidence, transmissibility and population susceptibility in a 9-year period. Influenza Other Respir Viruses. 2013;7(3):286-95. http://dx.doi.org/10.1111/j.1750-2659.2012.00388.x
18. Grant KA, Carville K, Fielding JE, Barr IG, Riddell MA, Tran T, et al. High proportion of influenza B characterises the 2008 influenza season in Victoria. Commun Dis Intell Q Rep. 2009;33(3):328-36.
19. Bodewes R, de Mutsert G, van der Klis FR, Ventresca M, Wilks S, Smith DJ, et al. Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. Clin Vaccine Immunol. 2011;18(3):469-76. http://dx.doi. org/10.1128/CVI.00396-10
20. Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature. 2012;484(7395):519-23. http://dx.doi. org/10.1038/nature10921
21. Public Health England (PHE). Surveillance of influenza and other respiratory viruses, including novel respiratory viruses, in the United Kingdom: Winter 2012/13. 2013. London: PHE; 2013. Available from: http://webarchive.nationalarchives. gov.uk/20140714084352/http://www.hpa.org.uk/webc/ HPAwebFile/HPAweb_C/1317139321787
22. Hedrick JA, Barzilai A, Behre U, Henderson FW, Hammond J, Reilly L, et al. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial. Pediatr Infect Dis J. 2000;19(5):410-7. http://dx.doi. org/10.1097/00006454-200005000-00005
23. Whitley RJ, Hayden FG, Reisinger KS, Young N, Dutkowski R, Ipe D, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001;20(2):127-33. http://dx.doi. org/10.1097/00006454-200102000-00002
24. Ferraris O, Kessler N, Lina B. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice. Antiviral Res. 2005;68(1):43-8. http://dx.doi.org/10.1016/j.antiviral.2005.07.004